Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s TresibaNovo Nordisk presented the latest results for its diabetes injectable Tresiba last weekend. These demonstrated significantly better control Share XReal-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresibahttps://pharmaphorum.com/news/tresiba-improved-sugar-control-decreased-hypos/
Novo’s Tresiba primed for key ‘hypo’ label update in EUFast-acting insulin also approved in US Share XNovo’s Tresiba primed for key ‘hypo’ label update in EUhttps://pharmaphorum.com/news/novos-tresiba-gets-key-hypo-label-update-eu/